Regulating by Repute
David T. Zaring
University of Pennsylvania - Legal Studies Department
May 3, 2012
Michigan Law Review, Vol. 110, No. 6, p. 1003, 2012
This review essay evaluates Daniel Carpenter’s theory that the Food and Drug Administration’s successful history is largely due to its strong reputation. Reputation is an increasingly popular explanation for legal compliance when a tally of the more immediate and tangible costs and benefits would suggest that noncompliance or shirking would be the more rational choice, and evaluating the way Carpenter explores reputation’s important to the FDA allows for a broader consideration of its role in regulatory projects more generally. Moreover, by delving into what the agency did once it was given the authority to permit or reject the sale of drugs in the American market, Carpenter offers an account of what happens in agencies after administrative law stops its usual inquiry – or, at least, after it did so in the case of the FDA. The essay explores the implications of that “ordinary governance” for the usual focuses of legal scholarship.
Number of Pages in PDF File: 16Accepted Paper Series
Date posted: May 3, 2012
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo3 in 0.407 seconds